SykoActive

Join us for an in-depth look at the Psychedelic retreat centers available in the United States and what you can do to prepare for your first ceremonial experience. With recent laws passing to decriminalize entheogens, psychonauts can now take psychedelics at health and wellness retreat centers and work with psychotherapists and modern shamans to heal, as interested Americans no longer have to travel to another country just to partake in these sacred plant medicines.

Join us as we take a look at the Companies in the mental health industry researching groundbreaking proprietary psychedelic drugs and the philanthropic fundraising and investment opportunities in the psychedelic industry. 

Don't miss this week's Trip Tales, as Grant Lane speaks about his trip on LSD and Psilocybin Mushrooms at a Lee Scratch Perry Concert! 

This week we will hear from an experienced psychonaut and psychedelic researcher, Michael Doty. Join us as we explore the research he is currently doing with psychedelics and his profound experience taking a legal hallucinogen called Syrian Rue. 

Michael Dody is on the board with Delos Psyche Research Group. Michael is also a psychotherapist, psychedelic researcher, and artist. Michael exhibited a keen interest in studying consciousness from a young age, often using methods such as hanging upside down, merry-go-rounds, and sensory deprivation using himself and his brothers as test subjects. His formal entry in studying consciousness came as an undergraduate at Indiana University Purdue University Indianapolis, where he double majored in psychology and philosophy, studying the role of psychedelics in Taoism and Buddhism, as well as the impact of spirituality on alcohol consumption. After receiving his master’s in counseling psychology from the California Institute of Integral Studies, Michael began working as a psychotherapist, specializing in the use of expressive arts therapy to foster personal growth. Michael is currently finishing coursework for his Ph.D. at Sofia University, where he is studying the therapeutic benefits of psychedelic medicine.